Par Specialty Pharmaceuticals is the proprietary products division of Par Pharmaceutical, Inc. We are bringing to market novel, proprietary products by applying innovative technologies, reformulation techniques and delivery systems to enhance their performance.

  • Launched in 2005 as Par Pharmaceutical, Inc.’s Proprietary Products Division.
  • Our mission is to improve molecules for specific patient populations whose needs aren’t being met by existing products, so their overall treatment experience is improved
  • Successes to date include the reformulation and launch of Megace® ES (megestrol acetate) oral suspension, and the re-launch of Nascobal® (Cyanocobalamin, USP) Nasal Spray.
  • Solid infrastructure of marketing, sales, legal, regulatory, managed care, and medical affairs to help prepare a product for launch and beyond

Combining the
energy and
innovation of a
new venture with
the resources of a
leading, diversified